ZYME vs LQDA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 11, 2026

ZYME

55.2
AI Score
VS
ZYME Wins

LQDA

41.4
AI Score

Investment Advisor Scores

ZYME

55score
Recommendation
STRONG BUY

LQDA

41score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric ZYME LQDA Winner
Forward P/E 65.3595 22.7273 LQDA
PEG Ratio 0 0 Tie
Revenue Growth -91.1% 4158.5% LQDA
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 55.2/100 41.4/100 ZYME
Profit Margin -126.3% 7.7% LQDA
Beta 1.00 1.00 Tie
AI Recommendation STRONG BUY HOLD ZYME

Relative Price Performance (Last 90 Days)

ZYME 1M: +24.0% · 3M: +14.2% LQDA 1M: -22.9% · 3M: +10.7%

Current Technical Phase

ZYME

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 72

RSI (14): 71.6 · Price: $28.67

LQDA

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 36

RSI (14): 35.7 · Price: $68.62

Fundamentals Snapshot

Metric ZYME LQDA
Market Cap
Forward P/E 24.4 12.2
Trailing P/E 53.8
Revenue (TTM)
Revenue Growth -0.9% 18.4%
Gross Margin -2.5% 0.9%
Operating Margin -9.2% 0.5%
EPS -2.02 1.32
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, ZYME is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.